SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001628280-23-011628
Filing Date
2023-04-14
Accepted
2023-04-14 16:16:01
Documents
16

Document Format Files

Seq Description Document Type Size
1 DEF 14A cort-20230413.htm   iXBRL DEF 14A 759181
6 cort-20230413_g1.jpg GRAPHIC 163542
7 cort-20230413_g2.jpg GRAPHIC 151434
  Complete submission text file 0001628280-23-011628.txt   2149858

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT cort-20230413.xsd EX-101.SCH 3583
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT cort-20230413_def.xml EX-101.DEF 4770
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT cort-20230413_lab.xml EX-101.LAB 6663
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT cort-20230413_pre.xml EX-101.PRE 3756
10 EXTRACTED XBRL INSTANCE DOCUMENT cort-20230413_htm.xml XML 133921
Mailing Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025
Business Address 149 COMMONWEALTH DRIVE MENLO PARK CA 94025 650.688.8803
CORCEPT THERAPEUTICS INC (Filer) CIK: 0001088856 (see all company filings)

IRS No.: 770487658 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-50679 | Film No.: 23821351
SIC: 2834 Pharmaceutical Preparations